Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months.

Phase 4

• Conditions: Osteoarthritis; Musculoskeletal Diseases; Rheumatic Diseases; Joint Diseases; Arthritis

• Registration Number: RPCEC00000222
• Lead Sponsor: Center of Natural Products, National Center for Scientific Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Women and men.
2. Ages between 20 and 80 years.
3. With symptoms of OA (joint pain in hip, spine, limbs and / or phalanges).
4. Which have agreed to give informed consent.
5. Patients classified in Scales I-III of the American Association of Rheumatology.
6. Patients with WOMAC score > 25.

Exclusion Criteria

1. Existence of other forms of arthritis.
2. Arthroplasty in the last 3 years.
3. Any orthopedic surgery in the last 3 years.
4. Transplanted.
5. Active liver disease or active kidney disease.
6. Neoplasms diagnosed.
7. Severe arterial hypertension
8. Uncompensated diabetes mellitus (fasting glucose > 7 mmol/L).
9. Hospitalization for any cause in the previous 6 months.
10. Subjects with normal clinical history of allergy to any other medicines or other special conditions that endanger their health and their lives during the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health Status (WOMAC questionnaire 0-Best health status, 96-worst health status). Measuring Time: At baseline, at the end of the 6, 12, 18 and 24 weeks. <br>